Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.

Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Abstract Text:

    carl e rubyCarl E Ruby,william l redmondWilliam L Redmond,daniel haleyDaniel Haley,andrew d weinbergAndrew D Weinberg,

    There is growing evidence that engagement of OX40 (CD134), a member of the TNF receptor superfamily, can directly stimulate antigen-specific CD8+ T cells. It has been shown that CD8+ T cells express OX40 following activation, but the response of antigen-specific CD8+ T cells to OX40 stimulation has not been fully characterized. We utilized an antigen-specific transgenic CD8+ T cell model (OT-I) to determine if OX40 engagement can boost the generation of antigen-specific CD8+ T cell memory. Our results demonstrate that enhanced OX40 costimulation, via an agonist anti-OX40 antibody, increases CD25 and phospho-Akt expression on the antigen-specific CD8+ T cells and significantly increases the generation of long-lived antigen-specific CD8+ memory T cells. The increased numbers of memory CD8+ T cells generated via anti-OX40 treatment still required the presence of CD4+ T cells for their long-term maintenance in vivo. In addition, anti-OX40 costimulation greatly enhanced antigen-specific CD8+ T cell recall responses. These data show that OX40 engagement in vivo increases the number of antigen-specific CD8+ memory T cells surviving after antigen challenge and has implications for the development of more potent vaccines against pathogens and cancer.

    Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Publishing Authors By Initials

    ce rubyCE Ruby,wl redmondWL Redmond,d haleyD Haley,ad weinbergAD Weinberg,

    For similar cells: blood cells: leukocytes: leukocytes, mononuclear: lymphocytes: lymphocyte subsets: t-lymphocyte subsets research abstracts see: cells: blood cells: leukocytes: leukocytes, mononuclear: lymphocytes: lymphocyte subsets: t-lymphocyte subsets research

    PUBMED ID PMID:

    MEDLINE DATE:

    Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: European journal of immunology

    VOLUME: 37

    Page Numbers: 157-66

    Journal Abbreviation: Eur. J. Immunol.

    ISSN: 0014-2980

    DAY: 3

    MONTH: Jan

    YEAR: 2007

    Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1273201

    Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Keywords Mesh Terms:

    KEYWORDS: T-Lymphocyte Subsets

    MESH TERMS: transplantation

    Chemical & Substance for Abstract: Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Information

    Substance Name: Tnfrsf4 protein, mouse

    Registry Number: 0

    Grant and Affiliation Information for Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.

    AFFILIATION: Laboratory of Basic Immunology, Earle A. Chiles Research Institute, Robert W. Franz Research Center, Providence Portland Medical Center, Portland, OR 97213, USA.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY: United States NCI

    GRANT: R01-CA102577-04

    ACRONYM: CA

    MEDLINETA: Eur J Immunol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News